Cancer targeting carfilzomib nanomedicine: a comprehensive review of delivery vehicles and efficacy.
Sign Up to like & getrecommendations! Published in 2025 at "Nanomedicine"
DOI: 10.1080/17435889.2025.2579621
Abstract: ABSTRACT Cancer therapy is an ever-changing landscape in constant demand of innovative approaches. Carfilzomib (CFZ) is a tetrapeptide epoxyketone covalent proteasome inhibitor currently approved for the treatment of refractory multiple myeloma. CFZ has a litany… read more here.
Keywords: cancer; review; delivery; cfz ... See more keywords